ReviewEuropean radiology2025
ESR Essentials: Gynaecological causes of acute pelvic pain in women: a primer for emergent evaluation-practice recommendations by the European Society of Emergency Radiology.
Review in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparative study of transabdominal ultrasound alone versus combined transabdominal and transvaginal ultrasound in gynecological acute abdomen.Quantitative imaging in medicine and surgery · 2026Article
- Non-Sexually Transmitted Infection (STI)-Related Pelvic Inflammatory Disease (PID).Microorganisms · 2025Review
- Reply to: Unenhanced magnetic resonance imaging for the evaluation of sonographically indeterminate ovarian and adnexal masses.Radiologia brasileiraArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute pelvic pain (APP) is a common presentation in women of all ages and has both gynaecological and non-gynaecological causes. In the emergency department, the suspected differential diagnosis dictates the chosen imaging modality. For premenopausal patients with APP, transabdominal ultrasound (TAUS) and transvaginal ultrasound (TVUS) are first-line investigations with high sensitivity and specificity for ectopic pregnancy, adnexal torsion, and ovarian cysts and their complications. US may also be valuable in pelvic inflammatory disease. When a non-gynaecological cause is suspected, contrast-enhanced CT (± transabdominal US) is indicated and has the advantage of 24/7 availability and lack of operator dependence. CT, however, may reveal an unexpected gynaecological cause of APP. When available, MRI is an excellent second test to improve diagnostic certainty in pregnant women when US is inconclusive-both for gynaecological and non-gynaecological conditions. MRI has a high diagnostic accuracy for pelvic inflammatory disease and tubo-ovarian abscesses. This article will enable readers to refresh their knowledge of common causes of APP and understand the histopathological processes involved in gynaecological causes of APP and how the imaging findings correlate. It will outline why different modalities are useful in different pathologies and help understand the limitations of each modality, including the requirement for operator expertise (US), relative lack of specificity/sensitivity (CT), and limited availability (MRI). This article excludes pregnancy-related causes of APP (apart from ectopic pregnancy) and also excludes non-gynaecological causes of APP. KEY POINTS: In female patients with acute pelvic pain, ultrasound is the best first modality in suspected gynaecological pathology. CT can be used when non-gynaecological causes of pain are suspected and when US is inconclusive. MRI has limited availability in an emergency setting and may be used in pelvic inflammatory disease and in pregnancy when US is inconclusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.